Literature DB >> 12488313

Absolute lymphocyte count as a predictive factor for response to monoclonal anti-CD20 antibody therapy.

D Decaudin, G Des Guetz, C Mathiot, J Dumont, P Hubert, A Vincent-Salomon, P Pouillart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12488313     DOI： 10.1093/annonc/mdg015

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma.

Authors:  Shogo Kumagai; Masaharu Tashima; Jun Fujikawa; Makoto Iwasaki; Yoshihiro Iwamoto; Yuki Sueki; Akiko Fukunaga; Soshi Yanagita; Momoko Nishikori; Akifumi Takaori-Kondo; Nobuyoshi Arima
Journal:  Int J Hematol       Date:  2014-04-23       Impact factor: 2.490

2.  Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas.

Authors:  Lajos Gergely; Andrea Váncsa; Zsófia Miltényi; Zsófia Simon; Sándor Baráth; Árpád Illés
Journal:  Pathol Oncol Res       Date:  2010-09-15       Impact factor: 3.201

3.  Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.

Authors:  Hsiling Chiu; Preeti Trisal; Chad Bjorklund; Soraya Carrancio; Estela G Toraño; Carla Guarinos; Despoina Papazoglou; Patrick R Hagner; Asma Beldi-Ferchiou; Karin Tarte; Marie-Hélène Delfau-Larue; Franck Morschhauser; Alan G Ramsay; Anita K Gandhi
Journal:  Br J Haematol       Date:  2019-02-14       Impact factor: 6.998

4.  Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study.

Authors:  Shing Fung Lee; Miguel Angel Luque-Fernandez
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.